BioCurex Inc. Develops New Format for Its RECAF Cancer Blood Test; Results Confirm Its Accuracy

RICHMOND, British Columbia, May 28, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that it has developed an ELISA blood test using RECAF technology and reports results comparable to its other test formats.